Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

Efficacy and safety of Shexiang Baoxin pill (MUSKARDIA) in patients with stable coronary artery disease: a multicenter, double-blind, placebo-controlled phase IV randomized clinical trial

Abstract. Background:. The Shexiang Baoxin Pill (MUSKARDIA) has been used for treating coronary artery disease (CAD) and angina for more than 30 years in China. Nevertheless, methodologically sound trials on the use of MUSKARDIA in CAD patients are scarce. The aim of the study is to determine the ef...

Full description

Bibliographic Details
Main Authors: Jun-Bo Ge, Wei-Hu Fan, Jing-Min Zhou, Hai-Ming Shi, Fu-Sui Ji, Yang Wu, Yu-Lan Zhao, Jun Qian, Yuan-Zhe Jin, Ying-Wu Liu, Sheng-Huang Wang, Sheng-Hu He, Ping Yang, Jie Wu, Feng Lu, Zi-Shan Hou, Yan-Jie Yin, Xiu-Yuan Hao
Format: Article
Language:English
Published: Wolters Kluwer 2021-01-01
Series:Chinese Medical Journal
Online Access:http://journals.lww.com/10.1097/CM9.0000000000001257

Internet

http://journals.lww.com/10.1097/CM9.0000000000001257

Similar Items